Combined effect of N-acetylcysteine (antioxidant) and 20 minute walk on quality of life in stable COPD (kali Khasi) patients
Not Applicable
Completed
- Conditions
- Health Condition 1: null- Stable COPD patients
- Registration Number
- CTRI/2016/06/007024
- Lead Sponsor
- Dr Vijay Tukaram Salve
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 100
Inclusion Criteria
Patients diagnosed as stable COPD on basis of FEV1 according to (GOLD guidelines 2010) of age 40yrs to 70 yrs
Exclusion Criteria
Patient in acute exacerbation in last 6weeks, patients with severe ischemic heart disease recent history of MI, stroke, severe hypertension (systolic >180 & diastolic >110),pulse >120, Patients who are unable to walk the predicted distance for their age in six minuteâ??s walk test, pregnant patients,elderly patients above 70 years.If in between the study patient present with acute exacerbation.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method There was statistically significant improvement in SGRQ-C score and quality of life in the study group P value 0.0001 while improvement in SGRQ-C score and quality of life in control group was not statistically significant.P value 0.118.Overall there was statistically significant improvement in SGRQ-C score and quality of life.P value 0.03 in the study group.Timepoint: Quality of life was assessed with Saint Geoerge Respiratory Questionaire-C(SGRQ-C) at the begining of the study and at the end of ten weeks.
- Secondary Outcome Measures
Name Time Method Same as primary outcome.Timepoint: There was improvement in the quality of life at the end of ten weeks in study group.